Lihuayi Weiyuan Chemical Co., Ltd.
600955.SS · SHH
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 7.80B | 803.68M | 788.66M | 607.77M | 1.11 |
| 2023 FY | 7.05B | 214.11M | 104.98M | 98.62M | 0.18 |
| 2024 FY | 9.52B | 91.97M | 56.30M | 56.59M | 0.10 |
| 2025 FY | 8.77B | -131.65M | -1.12B | -991.56M | -1.81 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 9.93B | 1.29B | 1.02B | 400.00M | 8.64B |
| 2023 FY | 12.89B | 4.26B | 902.23M | 2.55B | 8.63B |
| 2024 FY | 13.36B | 4.76B | 844.43M | 2.89B | 8.60B |
| 2025 FY | 11.95B | 4.26B | 721.52M | 3.07B | 7.60B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | 1.08B | -3.04B | -1.96B | -215.05M | -225.01M |
| 2023 FY | 613.86M | -4.38B | -3.75B | -116.91M | -798.50K |
| 2024 FY | 917.85M | -1.47B | -550.92M | -147.99M | 32.78M |
| 2025 FY | 590.91M | -589.52M | 1.38M | -16.39M | -122.90M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 11.42B | 10.81B | — | — | — |
| 2023 FY | 9.83B | 11.49B | — | — | — |
| 2024 FY | 8.64B | 10.69B | — | — | — |
| 2025 FY | 8.87B | 11.23B | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 Q2 | 2.19B | 17.54M | -12.80M | -4.93M | -0.01 |
| 2025 Q3 | 2.15B | 41.84M | -6.81M | -11.84M | -0.02 |
| 2025 Q4 | 2.02B | -112.72M | -906.86M | -812.18M | -1.48 |
| 2026 Q1 | 2.68B | 197.69M | 144.90M | 71.32M | 0.13 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2025 Q2 | 13.03B | 4.61B | 1.00B | 2.97B | 8.42B |
| 2025 Q3 | 13.14B | 4.73B | 1.26B | 3.52B | 8.41B |
| 2025 Q4 | 11.95B | 4.26B | 721.52M | 3.07B | 7.60B |
| 2026 Q1 | 11.22B | 3.55B | 390.25M | 2.42B | 7.67B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2025 Q2 | 508.15M | -155.54M | 352.61M | -40.92M | 420.10M |
| 2025 Q3 | 51.83M | -51.83M | — | — | 256.10M |
| 2025 Q4 | -66.23M | 66.23M | -109.37M | -25.80M | -537.63M |
| 2026 Q1 | 362.36M | -114.97M | 247.39M | -21.55M | -331.28M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2025 Q2 | 7.77B | 9.73B | — | — | — |
| 2025 Q3 | 7.95B | 10.21B | — | — | — |
| 2025 Q4 | 8.89B | 11.24B | — | — | — |
| 2026 Q1 | 9.51B | 11.54B | — | — | — |